arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

agilon health, inc.

AGL Health Care Misc Health and Biotechnology Services
$88.50
▲ +0.1% Today
as of Sep 4, 16:45 ET
Last 30 days -10.73% Jul 28 → Sep 04
$84.53 $90.79 $97.06 $103.32 $109.58 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$86.58
High
$88.50
Low
$86.53
Volume
$125,897
Avg Vol
$344,141
Mkt Cap
$1.5B
P/E (TTM)
22.24
Beta
—
52w High
$133.04
52w Low
$7.48
Div Yield
—
Shares Out
$17M

Recent Press Releases & News last 60 days · 20 items

Aug 28 · 13:40 Zacks
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Aug 27 · 20:05 PR Business Wire
agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology Conference
Aug 20 · 20:05 PR Business Wire
agilon health to Participate in Upcoming Conferences
▸ Show all 20 press releases & news Free account →

Overview

52-week range
$7.48
$133
65% of range
Avg surprise (last 3)
+10.7%
Avg reaction (last 2)
+6.2%
100% positive
Latest IV / EM
78%
EM ±12.2% · $90 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.25$0.26$0.77$1.29$1.80 Est $-0.01Actual $-0.25Est $-0.11Actual $1.80Est $1.13Actual $1.04 Mar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-118M$314M$746M$1.2B$1.6B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.04 — — — — financials
Wed May 6, 2026Mar/2026 $1.80 $1.13 +59.3% — +4.2% earnings
Mon Aug 4, 2025Jun/2025 $-0.25 $-0.11 -127.3% — — earnings
Tue May 6, 2025Mar/2025 — $-0.01 +100.0% — +8.3% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.49B$1.42B—$1.44B$1.39B$1.53B—$1.45B
Cost of revenue————————
Gross profit————————
Operating income$12M$4M—$-131M$-116M$-22M—$-134M
Net income$18M$49M—$-110M$-104M$12M—$-118M
EPS (diluted)$1.04$2.94——$-6.31$0.73——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$107M$140M$174M$172M$171M$137M$188M$148M
Inventory————————
Total current assets$1.42B$1.32B$1.10B$1.34B$1.45B$1.65B$1.46B$1.81B
Total assets$1.59B$1.50B$1.27B$1.60B$1.71B$1.93B$1.73B$2.09B
Long-term debt$15M$15M$16M$0$0$0$35M$35M
Total liabilities$1.36B$1.32B$1.14B$1.29B$1.30B$1.43B$1.26B$1.52B
Total equity$228M$181M$127M$306M$409M$500M—$575M

Implied volatility — last 90 days

76%93%111%128%146% Jun 07 — IV 117% · EM ±16.2%Jun 08 — IV 116% · EM ±15.3%Jun 09 — IV 118% · EM ±14.8%Jun 10 — IV 105% · EM ±12.4%Jun 11 — IV 108% · EM ±11.9%Jun 12 — IV 109% · EM ±11.2%Jun 15 — IV 120% · EM ±8.7%Jun 16 — IV 131% · EM ±7.7%Jun 17 — IV 131% · EM ±5.5%Jun 19 — IV 109% · EM ±24.0%Jun 22 — IV 106% · EM ±22.2%Jun 23 — IV 102% · EM ±20.9%Jun 24 — IV 99% · EM ±19.8%Jun 25 — IV 99% · EM ±19.3%Jun 26 — IV 97% · EM ±18.5%Jun 29 — IV 99% · EM ±17.6%Jun 30 — IV 99% · EM ±17.0%Jul 01 — IV 99% · EM ±16.5%Jul 02 — IV 95% · EM ±15.4%Jul 03 — IV 98% · EM ±15.4%Jul 06 — IV 103% · EM ±14.3%Jul 07 — IV 98% · EM ±12.9%Jul 08 — IV 96% · EM ±12.0%Jul 09 — IV 98% · EM ±11.6%Jul 10 — IV 87% · EM ±9.7%Jul 13 — IV 102% · EM ±8.5%Jul 14 — IV 120% · EM ±8.7%Jul 15 — IV 109% · EM ±6.4%Jul 16 — IV 112% · EM ±4.7%Jul 20 — IV 127% · EM ±30.0%Jul 21 — IV 126% · EM ±29.3%Jul 22 — IV 126% · EM ±28.8%Jul 23 — IV 132% · EM ±29.7%Jul 24 — IV 132% · EM ±29.2%Jul 27 — IV 139% · EM ±29.0%Jul 28 — IV 137% · EM ±27.9%Jul 29 — IV 137% · EM ±27.5%Jul 30 — IV 134% · EM ±26.3%Jul 31 — IV 139% · EM ±26.7%Aug 03 — IV 147% · EM ±26.0%Aug 04 — IV 146% · EM ±25.1%Aug 05 — IV 144% · EM ±24.1%Aug 06 — IV 100% · EM ±16.2%Aug 07 — IV 96% · EM ±15.0%Aug 10 — IV 93% · EM ±12.8%Aug 11 — IV 87% · EM ±11.5%Aug 12 — IV 91% · EM ±11.4%Aug 13 — IV 84% · EM ±9.9%Aug 14 — IV 88% · EM ±9.7%Aug 17 — IV 102% · EM ±8.5%Aug 18 — IV 101% · EM ±7.3%Aug 19 — IV 103% · EM ±6.1%Aug 20 — IV 109% · EM ±4.6%Aug 24 — IV 84% · EM ±17.6%Aug 25 — IV 76% · EM ±15.6%Aug 26 — IV 81% · EM ±16.2%Aug 27 — IV 82% · EM ±16.0%Aug 28 — IV 79% · EM ±15.1%Aug 31 — IV 82% · EM ±14.4%Sep 01 — IV 80% · EM ±13.7%Sep 02 — IV 83% · EM ±13.9%Sep 03 — IV 76% · EM ±12.3%Sep 04 — IV 78% · EM ±12.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in